<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[nuvaring Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/nuvaring.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to nuvaring]]></description>
	<s:counts start="0" returned="2" found="2" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Should We Be Surprised That Schering-Plough Execs Are "Surprised" By Sugammadex Rejection?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000153/should-we-be-surprised-that-schering-plough-execs-are-surprised-by-sugameddex-rejection/]]></link>
		<description><![CDATA[Yet another setback for Schering-Plough seems to have taken top management by surprise. Scheringâ€™s shares slid nearly four percent by midafternoon on the news that its sugammadex anesthesia-recovery drug would not be approved by the FDA.    In a statement, Schering VP Thomas Koestler said he was â€œsurprised...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 01 Aug 2008 13:13:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/diversity.html"><![CDATA[Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/schering.html"><![CDATA[Schering]]></category>
		<category domain="http://resources.bnet.com/topic/nuvaring.html"><![CDATA[NuvaRing]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/operational+accounting.html"><![CDATA[Operational Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
		<category domain="tickers">SGP</category>
	</item>
	<item>
		<title><![CDATA[NuvaRing(R), World's First Vaginal Birth Control Ring, Now Available In U.S.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200207/ai_mark05044589]]></link>
		<description><![CDATA[(NASDAQ: AKZOY) -- Women now have a unique, effective and convenient new monthly contraceptive option.  Organon Inc. today announced that NuvaRingR (etonogestrel/ethinyl estradiol vaginal ring), the world's first monthly vaginal ring for birth control, is now available in pharmacies nationwide.  NuvaRingR, is a small flexible, transparent ring that...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Jan 1970 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/nuvaring.html"><![CDATA[NuvaRing]]></category>
		<category domain="http://resources.bnet.com/topic/organon+inc..html"><![CDATA[Organon Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
